Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xiaoyong Lei
Therapeutic Activity of DCC-2036, a Novel Tyrosine Kinase Inhibitor, Against Triple-Negative Breast Cancer Patient-Derived Xenografts by Targeting AXL/MET
International Journal of Cancer
Cancer Research
Oncology
Cytoplasmic M‑CSF Facilitates Apoptosis Resistance by Inhibiting the HIF‑1α/BNIP3/Bax Signalling Pathway in McF‑7 Cells
Oncology Reports
Medicine
Cancer Research
Oncology
Related publications
Identification of Novel Therapeutic Targets for Triple-Negative Breast Cancer
Development of a Vaccine Targeting Triple-Negative Breast Cancer
Targeting C-Met Receptor Tyrosine Kinase by the DNA Aptamer SL1 as a Potential Novel Therapeutic Option for Myeloma
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
Targeting Tumour Microenvironment by Tyrosine Kinase Inhibitor
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Inhibiting Aurora Kinases Reduces Tumor Growth and Suppresses Tumor Recurrence After Chemotherapy in Patient-Derived Triple-Negative Breast Cancer Xenografts
Molecular Cancer Therapeutics
Cancer Research
Oncology
Targeting MYC for Triple-Negative Breast Cancer Treatment
Oncoscience
Cancer Research
Oncology
Therapeutic Landscape in Mutational Triple Negative Breast Cancer
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Activity of BET-proteolysis Targeting Chimeric (PROTAC) Compounds in Triple Negative Breast Cancer
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Pan-Tam Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti-Pd-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer
Cancer Research
Cancer Research
Oncology
